Opinion|Videos|November 30, 2023
How HER2 Targeted Therapies Fight HER2-Positive Metastatic Breast Cancer
Author(s)Sara M. Tolaney, MD, MPH
HER2-targeted therapies improve outcomes by shutting down growth signaling to cancer cells, targeted delivery of chemotherapy, or blocking intracellular signaling - all leveraging the HER2 receptor to better control metastatic breast cancer.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
3
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
4
New Combination Treatment Approach Studied in Pancreatic Cancer
5